CannLabs Inc. (CANL) financial statements (2022 and earlier)

Company profile

Business Address 3888 E. MEXICO AVENUE
DENVER, CO 80210
State of Incorp. NV
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

Current Assets
Cash, cash equivalents, and short-term investments1133 
Cash and cash equivalents1133 
Prepaid expense107 
Total current assets:26233 
Noncurrent Assets
Property, plant and equipment99617732
Intangible assets, net (including goodwill)21
Intangible assets, net (excluding goodwill)21  
Other noncurrent assets59 
Other undisclosed noncurrent assets(21)  
Total noncurrent assets:1,05617732
TOTAL ASSETS:1,31821032
Current Liabilities
Accounts payable and accrued liabilities, including:9322215
Accounts payable 2215
Interest and dividends payable3  
Other undisclosed accounts payable and accrued liabilities930  
Debt238 2
Due to related parties219  
Deferred revenue and credits120  
Other undisclosed current liabilities 8313
Total current liabilities:1,50910630
Noncurrent Liabilities
Long-term debt and lease obligation688  
Long-term debt, excluding current maturities300  
Capital lease obligations388  
Liabilities, other than long-term debt750  
Due to related parties750  
Total noncurrent liabilities:1,438  
Other undisclosed liabilities(1,630)  
Total liabilities:1,31710630
Stockholders' equity
Stockholders' equity attributable to parent, including:(1,629)1042
Preferred stock1  
Common stock651717
Additional paid in capital6,6871,5841,403
Accumulated deficit(1,606)  
Other undisclosed stockholders' equity attributable to parent(6,775)(1,497)(1,417)
Stockholders' equity attributable to noncontrolling interest(1,630)  
Other undisclosed stockholders' equity3,260  
Total stockholders' equity:11042

Income statement (P&L) ($ in thousands)

Revenue, net1,365  
Financial services revenue 16 
Cost of revenue
(Cost of Goods and Services Sold)
Gross profit:47884146
Operating expenses(3,666)(178)(173)
Other undisclosed operating income 16 
Operating loss:(3,188)(78)(26)
Nonoperating expense(55)(1) 
Other nonoperating expense (1) 
Interest and debt expense(50)(1)(1)
Loss from continuing operations before income taxes:(3,293)(80)(28)
Income tax expense (benefit)641 (5)
Loss before gain (loss) on sale of properties:(2,652)(80)(33)
Other undisclosed net loss(591)  
Net loss:(3,243)(80)(33)
Net income attributable to noncontrolling interest1,658  
Other undisclosed net income (loss) attributable to parent(22)15
Net loss attributable to parent:(1,606)(79)(28)
Preferred stock dividends and other adjustments(22)  
Net loss available to common stockholders, diluted:(1,629)(79)(28)

Comprehensive Income ($ in thousands)

Net loss:(3,243)(80)(33)
Comprehensive loss:(3,243)(80)(33)
Comprehensive income, net of tax, attributable to noncontrolling interest1,658  
Comprehensive loss, net of tax, attributable to parent:(1,584)(80)(33)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios


Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: